Citations (175)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (26)
Simone P. Carneiro, Antonietta Greco, Enrica Chiesa, Ida Genta & Olivia M. Merkel. (2023) Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases. Expert Opinion on Drug Delivery 20:4, pages 471-487.
Read now
Read now
Ville A Vartiainen, Federico Lavorini, Anna C Murphy & Klaus F Rabe. (2023) High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD. Expert Opinion on Drug Delivery 20:3, pages 385-393.
Read now
Read now
Gülbeyaz Yildiz Türkyilmaz, Kemal Volkan Özdokur, Levent Alparslan & Ercüment Karasulu. (2023) Sodium hyaluronate dry powder inhalation in combination with sodium cromoglycate prepared using optimized spray drying conditions. Pharmaceutical Development and Technology 28:2, pages 240-247.
Read now
Read now
Evalyne M Jansen, Henderik W Frijlink, Wouter LJ Hinrichs & Mitchel JR Ruigrok. (2022) Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opinion on Drug Delivery 19:11, pages 1471-1485.
Read now
Read now
Anne Haaije de Boer, Paul Hagedoorn & Floris Grasmeijer. (2022) Dry powder inhalation, part 2: the present and future. Expert Opinion on Drug Delivery 19:9, pages 1045-1059.
Read now
Read now
Anne Haaije de Boer, Paul Hagedoorn & Floris Grasmeijer. (2022) Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers. Expert Opinion on Drug Delivery 19:9, pages 1033-1044.
Read now
Read now
Loreana Gallo, Marcos Andrés Serain, Carlos Renaudo, Eduardo López & Verónica Bucalá. (2022) Influence of microbubbles on the production of spray-dried inhalable particles. Drying Technology 40:9, pages 1819-1831.
Read now
Read now
Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Read now
V. Chaugule, C.Y. Wong, K. Inthavong, D.F. Fletcher, P.M. Young, J. Soria & D. Traini. (2022) Combining experimental and computational techniques to understand and improve dry powder inhalers. Expert Opinion on Drug Delivery 19:1, pages 59-73.
Read now
Read now
Nan Ding, Wei Zhang, Zhuo Wang, Chong Bai, Qian He, Yuchao Dong, Xiumin Feng, Jingxi Zhang & Shen Gao. (2021) Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1913-1924.
Read now
Read now
Michael M. Lipp, Anthony J. Hickey, Robert Langer & Peter A. LeWitt. (2021) A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s disease. Expert Opinion on Drug Delivery 18:11, pages 1559-1569.
Read now
Read now
Sagar Pardeshi, Mahesh More, Pritam Patil, Chandrakantsing Pardeshi, Prashant Deshmukh, Arun Mujumdar & Jitendra Naik. (2021) A meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle engineering approaches for pharmaceutical technologies. Drying Technology 39:11, pages 1447-1491.
Read now
Read now
Anne M. Akkerman-Nijland, Onno W. Akkerman, Floris Grasmeijer, Paul Hagedoorn, Henderik. W. Frijlink, Bart. L. Rottier, Gerard. H. Koppelman & Daniel. J. Touw. (2021) The pharmacokinetics of antibiotics in cystic fibrosis. Expert Opinion on Drug Metabolism & Toxicology 17:1, pages 53-68.
Read now
Read now
Rachel Yoon Kyung Chang, Lan Chen, Donghao Chen & Hak-Kim Chan. (2020) Overcoming challenges for development of amorphous powders for inhalation. Expert Opinion on Drug Delivery 17:11, pages 1583-1595.
Read now
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Read now
Arzu Ari & James B Fink. (2020) Recent advances in aerosol devices for the delivery of inhaled medications. Expert Opinion on Drug Delivery 17:2, pages 133-144.
Read now
Read now
Nashwa M. Osman, Darren W. Sexton & Imran Y. Saleem. (2020) Toxicological assessment of nanoparticle interactions with the pulmonary system. Nanotoxicology 14:1, pages 21-58.
Read now
Read now
Jana Kozáková, Ayça Altay, Vladimír Ždímal, Ludmila Mašková, Fabio Sonvico, Eride Quarta, Alessandra Rossi, Francesca Buttini & Gaia Colombo. (2019) Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Drug Development and Industrial Pharmacy 45:10, pages 1664-1673.
Read now
Read now
M. Razuc, A. Grafia, L. Gallo, M. V. Ramírez-Rigo & R. J. Romañach. (2019) Near-infrared spectroscopic applications in pharmaceutical particle technology. Drug Development and Industrial Pharmacy 45:10, pages 1565-1589.
Read now
Read now
Alaa M. Ali, Ahmed S. Abo Dena, Magdi H. Yacoub & Ibrahim M. El-Sherbiny. (2019) Exploring the influence of particle shape and air velocity on the flowability in the respiratory tract: a computational fluid dynamics approach. Drug Development and Industrial Pharmacy 45:7, pages 1149-1156.
Read now
Read now
Kaksha Sankhe, Tabassum Khan, Chintan Bhavsar, Munira Momin & Abdelwahab Omri. (2019) Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB. Expert Opinion on Drug Delivery 16:5, pages 525-538.
Read now
Read now
Tulshidas S. Patil, Ashwini S. Deshpande, Shirish Deshpande & Pravin Shende. (2019) Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need. Journal of Drug Targeting 27:1, pages 12-27.
Read now
Read now
Vivek Viswanathan, Rajesh Pharande, Anilkumar Bannalikar, Pushpa Gupta, Umesh Gupta & Alka Mukne. (2019) Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies. Drug Development and Industrial Pharmacy 45:1, pages 11-20.
Read now
Read now
Elsa Bodier-Montagutelli, Alexie Mayor, Laurent Vecellio, Renaud Respaud & Nathalie Heuzé-Vourc’h. (2018) Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?. Expert Opinion on Drug Delivery 15:8, pages 729-736.
Read now
Read now
Nashwa Osman, Kan Kaneko, Valeria Carini & Imran Saleem. (2018) Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies. Expert Opinion on Drug Delivery 15:8, pages 821-834.
Read now
Read now
Ziyu Zhao, Zhengwei Huang, Xuejuan Zhang, Ying Huang, Yingtong Cui, Cheng Ma, Guanlin Wang, Tim Freeman, Xiang-yun Lu, Xin Pan & Chuanbin Wu. (2018) Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement. Expert Opinion on Drug Delivery 15:5, pages 443-457.
Read now
Read now
Articles from other publishers (149)
Vishal Chaugule, Larissa Gomes dos Reis, David F. Fletcher, Paul M. Young, Daniela Traini & Julio Soria. (2023) A counter-swirl design concept for dry powder inhalers. International Journal of Pharmaceutics, pages 123694.
Crossref
Crossref
Kifayatullah Shah, Lai Wah Chan & Tin Wui Wong. (2023) Conversion of liquid chitosan-based nanoemulsions into inhalable solid microparticles: Process challenges with polysaccharide. International Journal of Biological Macromolecules 253, pages 126991.
Crossref
Crossref
Sabrina Magramane, Kristina Vlahović, Péter Gordon, Nikolett Kállai-Szabó, Romána Zelkó, István Antal & Dóra Farkas. (2023) Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. Pharmaceuticals 16:12, pages 1658.
Crossref
Crossref
Qingzhen Zhang, Shanglong Kou, Yingtong Cui, Jie Dong, Yuqing Ye, Yuanyuan Wang, Rui Lu, Xinduo Li, Yi Nie, Kaiqi Shi, Fang Chen, Philip Hall, Xiaoling Chen, Zheng Wang & Xingtao Jiang. (2023) Ternary Dry Powder Agglomerate Inhalation Formulation of Melatonin With Air Jet Mixing to Improve In Vitro And In Vivo Performance. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Colleen McEvoy, Rahul Argula, Sandeep Sahay, Shelley Shapiro, Christina Eagan, Anthony J. Hickey, Chad Smutney, Chris Dillon, Thomas Winkler, Brittany Davis, Meredith Broderick & Charles Burger. (2023) Tyvaso DPI: Drug-device characteristics and patient clinical considerations. Pulmonary Pharmacology & Therapeutics, pages 102266.
Crossref
Crossref
Alexander Welle, Mohit Mehta, Karin Marek, Harry Peters, Peter van der Wel & Olukayode Imole. (2023) Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations. International Journal of Pharmaceutics 647, pages 123503.
Crossref
Crossref
Melvin Wostry & Regina Scherließ. (2023) Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation. European Journal of Pharmaceutical Sciences 190, pages 106583.
Crossref
Crossref
Zhaokui Jin, Qi Gao, Keke Wu, Jiang Ouyang, Weisheng Guo & Xing-Jie Liang. (2023) Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Advanced Drug Delivery Reviews 202, pages 115111.
Crossref
Crossref
Lorena Pasero, Francesca Susa, Riccardo Chiavarino, Tania Limongi, Adamo Sulpizi, Tomaso Guidi & Roberto Pisano. (2023) Tailoring Dry Microparticles for Pulmonary Drug Delivery: Ultrasonic Spray Freeze-Drying with Mannitol and Salbutamol Sulphate. Processes 11:11, pages 3096.
Crossref
Crossref
Anna Lechanteur, Eva Gresse, Luisa Orozco, Erwan Plougonven, Angélique Léonard, Nicolas Vandewalle, Geoffroy Lumay & Brigitte Evrard. (2023) Inhalation powder development without carrier: How to engineer ultra-flying microparticles?. European Journal of Pharmaceutics and Biopharmaceutics 191, pages 26-35.
Crossref
Crossref
Beatriz Behrend-Keim, Almendra Castro-Muñoz, Luis Monrreal-Ortega, Bárbara Ávalos-León, Carolina Campos-Estrada, Hugh D.C. Smyth, Tania F. Bahamondez-Canas & Daniel Moraga-Espinoza. (2023) The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide. International Journal of Pharmaceutics 644, pages 123331.
Crossref
Crossref
Mariana Yasue Saito Miyagi, Rafael de Oliveira Faria, Gabriel Batista de Souza, Claudiana Lameu, Tatsuaki Tagami, Tetsuya Ozeki, Vinícius Danilo Nonato Bezzon, Megumi Nishitani Yukuyama, Nadia Araci Bou-Chacra & Gabriel Lima Barros de Araujo. (2023) Optimizing adjuvant inhaled chemotherapy: Synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics 644, pages 123324.
Crossref
Crossref
Arzu Ari & Bshayer Ramadan Alhamad. (2023) Evaluating dry powder inhalers: From in vitro studies to mobile health technologies. Respiratory Medicine 215, pages 107281.
Crossref
Crossref
Thomas Hibbard, Hannah Mitchell, Yoonha Kim, Kenneth Shankland & Hisham Al-Obaidi. (2023) Spray dried progesterone formulations for carrier free dry powder inhalation. European Journal of Pharmaceutics and Biopharmaceutics 189, pages 264-275.
Crossref
Crossref
Ashish Sarode, Priyal Patel, Natalia Vargas-Montoya, Ayed Allawzi, Alisa Zhilin-Roth, Saswata Karmakar, Lianne Boeglin, Hongfeng Deng, Shrirang Karve & Frank DeRosa. (2023) Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery. Drug Delivery and Translational Research.
Crossref
Crossref
Hadeel Aburass, Nisreen Dahshan, Hamad Alyami, Affiong Iyire & Eman Zmaily Dahmash. (2023) Novel Nanoaggregates from Phoenix dactylifera (date palm) for Inhalational Management of Cystic Fibrosis Using Dry Powder Inhalers. Journal of Pharmaceutical Innovation.
Crossref
Crossref
Suraj L. Dongare & Minal R. Narkhede. (2023) An Overview of Recently Published Patents on Pulmonary Drug Delivery
Devices. Recent Advances in Drug Delivery and Formulation 17:2, pages 102-119.
Crossref
Crossref
Taha Sadeghi, Leila Pakzad & Pedram Fatehi. (2023) Evaluation of Soft Mist Inhaler Aerosol Velocity, Size, and Deposition Inside the Mouth—A Computational Fluid Dynamics Study. Journal of Biomechanical Engineering 145:6.
Crossref
Crossref
Mohammad Hasan Taheri, Nematollah Askari, Yaning Feng, Malikeh Nabaei, Mohammad S. Islam, Ali Farnoud & Xinguang Cui. (2023) Swirling flow and capillary diameter effect on the performance of an active dry powder inhalers. Medicine in Novel Technology and Devices 18, pages 100240.
Crossref
Crossref
Patricia Tang, Maziar Kakhi, Ahmed Albariqi, Srinivas Ravindra Babu Behara, Ross Walenga, Runyu Yang & Hak-Kim Chan. (2023) The role of capsule aperture size on the dispersion of carrier-based formulation at different air flowrates. International Journal of Pharmaceutics, pages 123152.
Crossref
Crossref
Hao-Ying Li & En-Yu Xu. (2023) Dual functional pullulan-based spray-dried microparticles for controlled pulmonary drug delivery. International Journal of Pharmaceutics 641, pages 123057.
Crossref
Crossref
Sohan Sarangi, Anna Simonsson & Göran Frenning. (2023) Segregation in inhalable powders: Quantification of the effect of vibration on adhesive mixtures. European Journal of Pharmaceutics and Biopharmaceutics 187, pages 107-119.
Crossref
Crossref
Ryosuke Mitani, Shuji Ohsaki, Hideya Nakamura & Satoru Watano. (2023) Numerical study on deposition of non-spherical shaped particles in cascade impactor. Advanced Powder Technology 34:6, pages 104045.
Crossref
Crossref
Dale Farkas, Morgan L. Thomas, Amr Hassan, Serena Bonasera, Michael Hindle & Worth Longest. (2022) Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI. Pharmaceutical Research 40:5, pages 1193-1207.
Crossref
Crossref
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, Nikita A. Waykhinde, Umesh D. Laddha, Kishor S. Salunkhe, Sanjay J. Kshirsagar, Sakshi S. Patil & Kuldeep H. Ramteke. (2023) Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies. Journal of Controlled Release 355, pages 292-311.
Crossref
Crossref
Cheryl L. Doherty, Amy L. Robertson, Nicola Clear & Robert Docherty. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
769
799
.
Nianxia Sun, Min Zhang, Wentao Zhu, Pingping Song, Tingting Dai, Peng Huang, Zhili Han & Dianlei Wang. (2023) Allyl isothiocyanate dry powder inhaler based on cyclodextrin-metal organic frameworks for pulmonary delivery. iScience 26:1, pages 105910.
Crossref
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
531
589
.
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
325
530
.
Abhinav Ram Mohan, Qiang Wang, Sneha Dhapare, Elizabeth Bielski, Anubhav Kaviratna, Liangfeng Han, Susan Boc & Bryan Newman. (2022) Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development. Pharmaceutics 14:11, pages 2495.
Crossref
Crossref
Ramin Ramezani Kalmer, Afzal Karimi, Mortaza Golizadeh, Mohsen Mohammadi Haddadan, Maryam Azizi, Hamed Ramezanalizadeh & Mojgan Ghanbari. (2022) Effect of different molecular weights of polyethylene glycol as a plasticizer on the formulation of dry powder inhaler capsules: Investigation of puncturing size, morphologies, and surface properties. Arabian Journal of Chemistry 15:11, pages 104239.
Crossref
Crossref
Bryan Newman, Andrew Babiskin, Elizabeth Bielski, Susan Boc, Sneha Dhapare, Lanyan Fang, Katharine Feibus, Anubhav Kaviratna, Bing V. Li, Markham C. Luke, Tian Ma, Michael Spagnola, Ross L. Walenga, Zhong Wang, Liang Zhao, Nashwa El-Gendy, Craig M. Bertha, Mohammed Abd El-Shafy & Dhaval K. Gaglani. (2022) Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective. Advanced Drug Delivery Reviews 190, pages 114526.
Crossref
Crossref
Gokben Sahin, Ozlem Akbal-Dagistan, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Serap Sancar & Ayca Yildiz-Pekoz. (2022) Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment. Journal of Pharmaceutical Sciences 111:10, pages 2652-2661.
Crossref
Crossref
Gerald A. Hebbink, Maarten Jaspers, Harry J.W. Peters & Bastiaan H.J. Dickhoff. (2022) Recent developments in lactose blend formulations for carrier-based dry powder inhalation. Advanced Drug Delivery Reviews 189, pages 114527.
Crossref
Crossref
Conor A. Ruzycki, Scott Tavernini, Andrew R. Martin & Warren H. Finlay. (2022) Characterization of dry powder inhaler performance through experimental methods. Advanced Drug Delivery Reviews 189, pages 114518.
Crossref
Crossref
Jesse Capecelatro, Worth Longest, Connor Boerman, Mostafa Sulaiman & Sankaran Sundaresan. (2022) Recent developments in the computational simulation of dry powder inhalers. Advanced Drug Delivery Reviews 188, pages 114461.
Crossref
Crossref
Francesca Orsola Alfano, Alberto Di Renzo, Roberto Gaspari, Andrea Benassi & Francesco Paolo Di Maio. (2022) Modelling Deaggregation Due to Normal Carrier–Wall Collision in Dry Powder Inhalers. Processes 10:8, pages 1661.
Crossref
Crossref
Yingjie Chen, Shen Yan, Shengyu Zhang, Quanyi Yin, Xiao Dong Chen & Winston Duo Wu. (2022) Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation. AAPS PharmSciTech 23:6.
Crossref
Crossref
Jiawei Wang, Xiangjun Kong, Linfeng Hu & Yuanjia Hu. (2022) Dry powder inhalers: A patent review. Journal of Drug Delivery Science and Technology 74, pages 103540.
Crossref
Crossref
Lucilla C. Almeida, Rahul Bharadwaj, Avi Eliahu, Carl R. Wassgren, Karthik Nagapudi & Ariel R. Muliadi. (2022) Capsule-Based dry powder inhaler evaluation using CFD-DEM simulations and next generation impactor data. European Journal of Pharmaceutical Sciences 175, pages 106226.
Crossref
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Crossref
BARTŁOMIEJ ROSPOND, AGATA KRAKOWSKA, BOŻENA MUSZYŃSKA & WŁODZIMIERZ OPOKA. (2022) The history, current state and perspectives of aerosol therapy. Acta Pharmaceutica 72:2, pages 225-243.
Crossref
Crossref
Mellissa GomezReinhard Vehring. (2022) Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines. Journal of Aerosol Medicine and Pulmonary Drug Delivery 35:3, pages 121-138.
Crossref
Crossref
Mina Mehanny, Annette Boese, Behnoosh Bornamehr, Jessica Hoppstädter, Volker Presser, Alexandra K. Kiemer, Claus-Michael Lehr & Gregor Fuhrmann. (2022) Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. International Journal of Pharmaceutics 621, pages 121794.
Crossref
Crossref
Nicholas Bungert, Mirjam Kobler & Regina Scherließ. (2022) The role of intrinsic fines in the performance change of expired lactose carriers for DPI applications. European Journal of Pharmaceutics and Biopharmaceutics 175, pages 7-12.
Crossref
Crossref
Jamie E. Spahn, Feng Zhang & Hugh D.C. Smyth. (2022) Mixing of dry powders for inhalation: A review. International Journal of Pharmaceutics 619, pages 121736.
Crossref
Crossref
Regina Scherließ, Simon Bock, Nicholas Bungert, Anna Neustock & Lena Valentin. (2022) Particle engineering in dry powders for inhalation. European Journal of Pharmaceutical Sciences 172, pages 106158.
Crossref
Crossref
Peng Lu, Jiawei Li, Chuanxin Liu, Jian Yang, Hui Peng, Zhifeng Xue & Zhidong Liu. (2022) Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis. Asian Journal of Pharmaceutical Sciences 17:3, pages 447-461.
Crossref
Crossref
Jonas Rudén, Göran Frenning, Tobias Bramer, Kyrre Thalberg & Göran Alderborn. (2022) Effect of pressure drop on the in vitro dispersion of adhesive mixtures of different blend states for inhalation. International Journal of Pharmaceutics 617, pages 121590.
Crossref
Crossref
Hui Wang, Mani Ordoubadi, Patrick Connaughton, Kellisa Lachacz, Nicholas Carrigy, Scott Tavernini, Andrew R. Martin, Warren H. Finlay, David Lechuga-Ballesteros & Reinhard Vehring. (2022) Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery. Pharmaceutical Research 39:4, pages 805-823.
Crossref
Crossref
Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S. Alyami, Hussien AbdulKarim, Mohammad H. Alyami & Alhassan H. Aodah. (2022) Novel Thymoquinone Nanoparticles Using Poly(ester amide) Based on L-Arginine-Targeting Pulmonary Drug Delivery. Polymers 14:6, pages 1082.
Crossref
Crossref
Mohammad H. Alyami, Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S. Alyami, Hussien AbdulKarim & Samar A. Alsudir. (2022) Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine. Pharmaceuticals 15:3, pages 321.
Crossref
Crossref
Siqin He, Jiajia Gui, Kun Xiong, Meiwan Chen, Huile Gao & Yao Fu. (2022) A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Jun Yee Tse, Kazunori Kadota, Toshiki Nakajima, Hiromasa Uchiyama, Shunsuke Tanaka & Yuichi Tozuka. (2021) Crystalline Rearranged CD-MOF Particles Obtained via Spray-Drying Synthesis Applied to Inhalable Formulations with High Drug Loading. Crystal Growth & Design 22:2, pages 1143-1154.
Crossref
Crossref
Annalisa Bianchera, Esraa Alomari & Stefano Bruno. (2022) Augmentation Therapy with Alpha-1 Antitrypsin: Present and Future
of Production, Formulation, and Delivery. Current Medicinal Chemistry 29:3, pages 385-410.
Crossref
Crossref
Anna Lechanteur, Erwan Plougonven, Luisa Orozco, Geoffroy Lumay, Nicolas Vandewalle, Angélique Léonard & Brigitte Evrard. (2022) Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior. International Journal of Pharmaceutics 613, pages 121319.
Crossref
Crossref
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Alaa M. Ali, Ahmed S. Abo Dena, Magdi H. Yacoub & Ibrahim M. El-Sherbiny. (2022) Drag-minimizing spore/pollen-mimicking microparticles for enhanced pulmonary drug delivery: CFD and experimental studies. Journal of Drug Delivery Science and Technology 67, pages 102960.
Crossref
Crossref
Yingtong Cui, Ying Huang, Xuejuan Zhang, Xiangyun Lu, Jun Xue, Guanlin Wang, Ping Hu, Xiao Yue, Ziyu Zhao, Xin Pan & Chuanbin Wu. (2022) A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes. Acta Pharmaceutica Sinica B 12:1, pages 437-450.
Crossref
Crossref
Elena Haettig & Marc Schneider. 2022. Essentials of Industrial Pharmacy. Essentials of Industrial Pharmacy
123
149
.
Orrin Devinsky, Kelly Kraft, Lorraine Rusch, Melanie Fein & Andrea Leone-Bay. (2021) Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study. Journal of Pharmaceutical Sciences 110:12, pages 3946-3952.
Crossref
Crossref
Jonas Rudén, Göran Frenning, Tobias Bramer, Kyrre Thalberg & Göran Alderborn. (2021) On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients. International Journal of Pharmaceutics: X 3, pages 100069.
Crossref
Crossref
Małgorzata Kubczak, Sylwia Michlewska, Maria Bryszewska, Achim Aigner & Maksim Ionov. (2021) Nanoparticles for local delivery of siRNA in lung therapy. Advanced Drug Delivery Reviews 179, pages 114038.
Crossref
Crossref
Francesca Buttini, Eride Quarta, Chiara Allegrini & Federico Lavorini. (2021) Understanding the Importance of Capsules in Dry Powder Inhalers. Pharmaceutics 13:11, pages 1936.
Crossref
Crossref
Eride Quarta, Fabio Sonvico, Ruggero Bettini, Claudio De Luca, Alessandro Dotti, Daniele Catalucci, Michele Iafisco, Lorenzo Degli Esposti, Gaia Colombo, Giovanna Trevisi, Dimitrios M. Rekkas, Alessandra Rossi, Tin Wui Wong, Francesca Buttini & Paolo Colombo. (2021) Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design. Pharmaceutics 13:11, pages 1825.
Crossref
Crossref
Heejun Park, Eun-Sol Ha & Min-Soo Kim. (2021) Surface modification strategies for high-dose dry powder inhalers. Journal of Pharmaceutical Investigation 51:6, pages 635-668.
Crossref
Crossref
Leah M. Mann, Sarah A. Angus, Connor J. Doherty & Paolo B. Dominelli. (2021) Evaluation of sex-based differences in airway size and the physiological implications. European Journal of Applied Physiology 121:11, pages 2957-2966.
Crossref
Crossref
V. V. Arkhipov. (2021) Respimat as the new standard for inhalation therapy devices. Meditsinskiy sovet = Medical Council:16, pages 32-37.
Crossref
Crossref
Jianan Zhao, Yu Feng, Kenichiro Koshiyama & Huimin Wu. (2021) Prediction of airway deformation effect on pulmonary air-particle dynamics: A numerical study. Physics of Fluids 33:10.
Crossref
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2021) Leucine as an excipient in spray dried powder for inhalation. Drug Discovery Today 26:10, pages 2384-2396.
Crossref
Crossref
Beatriz Noriega-Fernandes, Maria Malmlöf, Mattias Nowenwik, Per Gerde, M. Luisa Corvo & Eunice Costa. (2021) Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution. International Journal of Pharmaceutics 607, pages 121025.
Crossref
Crossref
Li Ding, Ashlee D. Brunaugh, Sven Stegemann, Scott V. Jermain, Matthew J. Herpin, Justin Kalafat & Hugh D. C. Smyth. (2021) A Quality by Design Framework for Capsule-Based Dry Powder Inhalers. Pharmaceutics 13:8, pages 1213.
Crossref
Crossref
Mellissa Gomez, Joseph McCollum, Hui Wang, Shital Bachchhav, Isobel Tetreau, Alana Gerhardt, Chris Press, Ryan M. Kramer, Christopher B. Fox & Reinhard Vehring. (2021) Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery. Vaccine 39:35, pages 5025-5036.
Crossref
Crossref
Eleonora Casula, Maria Letizia Manca, Matteo Perra, Jose Luis Pedraz, Tania Belen Lopez-Mendez, Antonio Lozano, Esteban Calvo, Marco Zaru & Maria Manconi. (2021) Nasal Spray Formulations Based on Combined Hyalurosomes and Glycerosomes Loading Zingiber officinalis Extract as Green and Natural Strategy for the Treatment of Rhinitis and Rhinosinusitis. Antioxidants 10:7, pages 1109.
Crossref
Crossref
Shuang Chen, Xiaohong Yang, Yan Zhang, Yun Liu, Hui Lu, Yanfei Qiu, Liting Cheng, Chong Li & Chenhui Wang. (2021) Inhalable Porous Microspheres Loaded with Metformin and Docosahexaenoic Acid Suppress Tumor Metastasis by Modulating Premetastatic Niche. Molecular Pharmaceutics 18:7, pages 2622-2633.
Crossref
Crossref
Pratik Adhikary, Sashi Kandel, Umar‐Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien‐Yu Lin, Evanthia Omoscharka & Kun Cheng. (2021) Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity. Advanced Therapeutics 4:7.
Crossref
Crossref
Qiuying Liao, Shuofeng Yuan, Jianli Cao, Kaiming Tang, Yingshan Qiu, Han Cong Seow, Rico Chi‐Hang Man, Zitong Shao, Yaoqiang Huang, Ronghui Liang, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen & Jenny Ka‐Wing Lam. (2021) Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus. Advanced Therapeutics 4:7.
Crossref
Crossref
Thorben Fischer, Inga Winter, Robert Drumm & Marc Schneider. (2021) Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA. Pharmaceutics 13:6, pages 844.
Crossref
Crossref
R. Ponzini, R. Da Vià, S. Bnà, C. Cottini & A. Benassi. (2021) Coupled CFD-DEM model for dry powder inhalers simulation: Validation and sensitivity analysis for the main model parameters. Powder Technology 385, pages 199-226.
Crossref
Crossref
Thoa Duong, Clara López-Iglesias, Piotr K. Szewczyk, Urszula Stachewicz, Joana Barros, Carmen Alvarez-Lorenzo, Mohammad Alnaief & Carlos A. García-González. (2021) A Pathway From Porous Particle Technology Toward Tailoring Aerogels for Pulmonary Drug Administration. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Susan Boc, Mohammad A. M. Momin, Dale R. Farkas, Worth Longest & Michael Hindle. (2021) Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations. AAPS PharmSciTech 22:4.
Crossref
Crossref
Yajie Zhang, Daniel A. Davis, Khaled AboulFotouh, Jieliang Wang, Donna Williams, Akhilesh Bhambhani, Michael Zakrewsky, Mohammed Maniruzzaman, Zhengrong Cui & Robert O. WilliamsIIIIII. (2021) Novel formulations and drug delivery systems to administer biological solids. Advanced Drug Delivery Reviews 172, pages 183-210.
Crossref
Crossref
Nicholas Bungert, Mirjam Kobler & Regina Scherließ. (2021) In-Depth Comparison of Dry Particle Coating Processes Used in DPI Particle Engineering. Pharmaceutics 13:4, pages 580.
Crossref
Crossref
Ryosuke Mitani, Shuji Ohsaki, Hideya Nakamura & Satoru Watano. (2021) Analysis of Adhesion Mechanism of DPIs in Oral Cavity粉末吸入製剤の口腔内における付着現象の解析. Journal of the Society of Powder Technology, Japan 58:3, pages 127-137.
Crossref
Crossref
Simoni Christou, Thanasis Chatziathanasiou, Stelios Angeli, Pantelis Koullapis, Fotos Stylianou, Josué Sznitman, Haiwei Henry Guo & Stavros C. Kassinos. (2021) Anatomical variability in the upper tracheobronchial tree: sex-based differences and implications for personalized inhalation therapies. Journal of Applied Physiology 130:3, pages 678-707.
Crossref
Crossref
Mitchel J.R. Ruigrok, Henderik W. Frijlink, Barbro N. Melgert, Peter Olinga & Wouter L.J. Hinrichs. (2021) Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Molecular Therapy - Methods & Clinical Development 20, pages 483-496.
Crossref
Crossref
Karl Bass, Dale Farkas, Amr Hassan, Serena Bonasera, Michael Hindle & P. Worth Longest. (2021) High-efficiency dry powder aerosol delivery to children: Review and application of new technologies. Journal of Aerosol Science 153, pages 105692.
Crossref
Crossref
Juan David Escobar-García, Cristina Prieto, Maria Pardo-Figuerez & Jose M. Lagaron. (2021) Room Temperature Nanoencapsulation of Bioactive Eicosapentaenoic Acid Rich Oil within Whey Protein Microparticles. Nanomaterials 11:3, pages 575.
Crossref
Crossref
Surinder K. Jindal, K. K. Pandey & P. P. Bose. (2022) Dry Powder Inhalers: Particle Size and Patient-Satisfaction. Indian Journal of Respiratory Care 10:1, pages 14-18.
Crossref
Crossref
You Xu, Aneesh Thakur, Yibang Zhang & Camilla Foged. (2021) Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 13:2, pages 177.
Crossref
Crossref
David Barona, Abouzar Shamsaddini, Maximilian Aisenstat, Kyrre Thalberg, David Lechuga-Ballesteros, Behzad Damadzadeh & Reinhard Vehring. (2021) Modulated Uniaxial Compression Analysis of Respirable Pharmaceutical Powders. KONA Powder and Particle Journal 38:0, pages 209-225.
Crossref
Crossref
Ian E. Stewart, Ignacio Luz & Ninell P. Mortensen. (2021) Consideration of Metal Organic Frameworks for Respiratory Delivery. KONA Powder and Particle Journal 38:0, pages 136-154.
Crossref
Crossref
Bhavya Vishwa, Afrasim Moin, D. V. Gowda, Syed M. D. Rizvi, Wael A. H. Hegazy, Amr S. Abu Lila, El-Sayed Khafagy & Ahmed N. Allam. (2021) Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis. Pharmaceutics 13:1, pages 79.
Crossref
Crossref
Mellissa Gomez, Joseph McCollum, Hui Wang, Mani Ordoubadi, Chester Jar, Nicholas B. Carrigy, David Barona, Isobel Tetreau, Michelle Archer, Alana Gerhardt, Chris Press, Christopher B. Fox, Ryan M. Kramer & Reinhard Vehring. (2021) Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. International Journal of Pharmaceutics 593, pages 120121.
Crossref
Crossref
Kyrre Thalberg, Foteini Papathanasiou, Magnus Fransson & Mark Nicholas. (2021) Controlling the performance of adhesive mixtures for inhalation using mixing energy. International Journal of Pharmaceutics 592, pages 120055.
Crossref
Crossref
Larissa Gomes dos Reis, Vishal Chaugule, David F. Fletcher, Paul M. Young, Daniela Traini & Julio Soria. (2021) In-vitro and particle image velocimetry studies of dry powder inhalers. International Journal of Pharmaceutics 592, pages 119966.
Crossref
Crossref
Michael Y.T. Chow, Rachel Yoon Kyung Chang & Hak-Kim Chan. (2021) Inhalation delivery technology for genome-editing of respiratory diseases. Advanced Drug Delivery Reviews 168, pages 217-228.
Crossref
Crossref
Anne Haaije de Boer & Kyrre Thalberg. 2021. Inhaled Medicines. Inhaled Medicines
99
146
.
Shahir Aziz, Regina Scherlieβ & Hartwig Steckel. (2020) Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia. Pharmaceutics 12:12, pages 1154.
Crossref
Crossref
Wanling Liang, Harry W. Pan, Driton Vllasaliu & Jenny K. W. Lam. (2020) Pulmonary Delivery of Biological Drugs. Pharmaceutics 12:11, pages 1025.
Crossref
Crossref
Dale Farkas, Serena Bonasera, Karl Bass, Michael Hindle & P. Worth Longest. (2020) Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface. Pharmaceutical Research 37:9.
Crossref
Crossref
Ryosuke Mitani, Shuji Ohsaki, Hideya Nakamura & Satoru Watano. (2020) Numerical Study on Particle Adhesion in Dry Powder Inhaler Device. Chemical and Pharmaceutical Bulletin 68:8, pages 726-736.
Crossref
Crossref
Nancy Hertel, Gudrun Birk & Regina Scherließ. (2020) Performance tuning of particle engineered mannitol in dry powder inhalation formulations. International Journal of Pharmaceutics 586, pages 119592.
Crossref
Crossref
Maria Malamatari, Anastasia Charisi, Stavros Malamataris, Kyriakos Kachrimanis & Ioannis Nikolakakis. (2020) Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation. Processes 8:7, pages 788.
Crossref
Crossref
Hiroyuki Yoshida, Akiko Usui, Yasuhiro Abe, Yukihiro Goda & Ken-ichi Izutsu. (2020) Relationship Between Geometric and Aerodynamic Particle Size Distributions in the Formulation of Solution and Suspension Metered-Dose Inhalers. AAPS PharmSciTech 21:5.
Crossref
Crossref
Eride Quarta, Veronica Chierici, Lisa Flammini, Massimiliano Tognolini, Elisabetta Barocelli, Anna Maria Cantoni, Gabriela Dujovny, Susana Ecenarro Probst, Fabio Sonvico, Gaia Colombo, Alessandra Rossi, Ruggero Bettini, Paolo Colombo & Francesca Buttini. (2020) Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats. Journal of Controlled Release 323, pages 412-420.
Crossref
Crossref
P. Gajjar, I.D. Styliari, T.T.H. Nguyen, J. Carr, X. Chen, J.A. Elliott, R.B. Hammond, T.L. Burnett, K. Roberts, P.J. Withers & D. Murnane. (2020) 3D characterisation of dry powder inhaler formulations: Developing X-ray micro computed tomography approaches. European Journal of Pharmaceutics and Biopharmaceutics 151, pages 32-44.
Crossref
Crossref
Moritz Beck-Broichsitter. (2020) Polymer-coated aperture plates for tailored atomization processes. Materials Science and Engineering: C 110, pages 110666.
Crossref
Crossref
Torben Sebastian Last, Niclas Roxhed & Goran Stemme. (2020) A Self-Sealing Spray Nozzle for Aerosol Drug Delivery. Journal of Microelectromechanical Systems 29:2, pages 182-189.
Crossref
Crossref
Dale FarkasMichael HindleSerena BonaseraKarl BassWorth Longest. (2020) Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:2, pages 83-98.
Crossref
Crossref
Andrew R. ClarkJeffry G. WeersRajiv Dhand. (2020) The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:1, pages 1-11.
Crossref
Crossref
Donald G. Grosset, Rohit Dhall, Tanya Gurevich, Jan Kassubek, Werner H. Poewe, Olivier Rascol, Monika Rudzinska, Jennifer Cormier, Alexander Sedkov & Charles Oh. (2020) Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. Parkinsonism & Related Disorders 71, pages 4-10.
Crossref
Crossref
Anna Lechanteur & Brigitte Evrard. (2020) Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. Pharmaceutics 12:1, pages 55.
Crossref
Crossref
Mónica Helena Correia Pereira, João Miguel Bettencourt Sena Carvalho, Paula Maria Gonçalves Pinto & Maria do Carmo Oliveira Cordeiro. 2020. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients
180
192
.
Eleonore Fröhlich, Kristin Öhlinger, Claudia Meindl, Carolina Corzo, Dirk Lochmann, Sebastian Reyer & Sharareh Salar-Behzadi. (2020) In vitro toxicity screening of polyglycerol esters of fatty acids as excipients for pulmonary formulations. Toxicology and Applied Pharmacology 386, pages 114833.
Crossref
Crossref
P. Gajjar, I.D. Styliari, T.T.H. Nguyen, J. Carr, X. Chen, J.A. Elliott, R.B. Hammond, T.L. Burnett, K. Roberts, P.J. Withers & D. Murnane. (2020) WITHDRAWN: 3D characterisation of dry powder inhaler formulations: Developing X-ray micro computed tomography approaches. International Journal of Pharmaceutics, pages 118988.
Crossref
Crossref
Anthony J. Hickey. (2020) Emerging trends in inhaled drug delivery. Advanced Drug Delivery Reviews 157, pages 63-70.
Crossref
Crossref
Tomasz R. Sosnowski. 2020. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications
327
344
.
Mohammad R. Tamadondar & Anders Rasmuson. (2019) The effect of carrier surface roughness on wall collision‐induced detachment of micronized pharmaceutical particles. AIChE Journal 66:1.
Crossref
Crossref
Ziyu Zhao, Xuejuan Zhang, Yingtong Cui, Ying Huang, Zhengwei Huang, Guanlin Wang, Ruifeng Liang, Xin Pan, Liang Tao & Chuanbin Wu. (2019) Hydroxypropyl-β-cyclodextrin as anti-hygroscopicity agent inamorphous lactose carriers for dry powder inhalers. Powder Technology 358, pages 29-38.
Crossref
Crossref
Maretti, Rustichelli, Lassinantti Gualtieri, Costantino, Siligardi, Miselli, Buttini, Montecchi, Leo, Truzzi & Iannuccelli. (2019) The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. Pharmaceutics 11:10, pages 508.
Crossref
Crossref
Yu Lin, Rachel Yoon Kyung Chang, Warwick J. Britton, Sandra Morales, Elizabeth Kutter, Jian Li & Hak-Kim Chan. (2019) Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 543-552.
Crossref
Crossref
Pantelis Koullapis, Bo Ollson, Stavros C. Kassinos & Josué Sznitman. (2019) Multiscale in silico lung modeling strategies for aerosol inhalation therapy and drug delivery. Current Opinion in Biomedical Engineering 11, pages 130-136.
Crossref
Crossref
Ian E. Stewart, Pradeep B. Lukka, Jiuyu Liu, Bernd Meibohm, Mercedes Gonzalez-Juarrero, Miriam S. Braunstein, Richard E. Lee & Anthony J. Hickey. (2019) Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599. Pharmaceutical Research 36:9.
Crossref
Crossref
Farideh Shiehzadeh, Farzin Hadizadeh, Amirhoushang Mohammadpour, Ehsan Aryan, Leila Gholami & Mohsen Tafaghodi. (2019) Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule. Journal of Drug Delivery Science and Technology 52, pages 957-967.
Crossref
Crossref
Benedict Benque & Johannes G. Khinast. (2019) Understanding the motion of hard-shell capsules in dry powder inhalers. International Journal of Pharmaceutics 567, pages 118481.
Crossref
Crossref
Moritz Graf, Christian E. Ziegler, Manuel Gregoritza & Achim M. Goepferich. (2019) Hydrogel microspheres evading alveolar macrophages for sustained pulmonary protein delivery. International Journal of Pharmaceutics 566, pages 652-661.
Crossref
Crossref
Xiaoxiao Hu, Caifen Wang, Lebing Wang, Zhaoxin Liu, Li Wu, Guoqing Zhang, Lin Yu, Xiaohong Ren, Peter York, Lixin Sun, Jiwen Zhang & Haiyan Li. (2019) Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide. International Journal of Pharmaceutics 564, pages 153-161.
Crossref
Crossref
Mohammad R. Tamadondar, Lilian de Martín & Anders Rasmuson. (2019) Agglomerate breakage and adhesion upon impact with complex‐shaped particles. AIChE Journal 65:6.
Crossref
Crossref
Tina Gulin-Sarfraz, Sofia Jonasson, Elisabeth Wigenstam, Eva von Haartman, Anders Bucht & Jessica Rosenholm. (2019) Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation. Pharmaceutics 11:4, pages 149.
Crossref
Crossref
Jeffry G. Weers, Danforth P. Miller & Thomas E. Tarara. (2019) Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles. AAPS PharmSciTech 20:3.
Crossref
Crossref
Jeffry G. WeersYoen-Ju SonMark GluskerAlfred HaynesDaniel HuangNani KadrichuJohn LeXue LiRichard MalcolmsonDanforth P. MillerThomas E. TararaKeith UngAndy Clark. (2019) Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:2, pages 55-69.
Crossref
Crossref
Jonas Rudén, Göran Frenning, Tobias Bramer, Kyrre Thalberg, Junxue An & Göran Alderborn. (2019) Linking carrier morphology to the powder mechanics of adhesive mixtures for dry powder inhalers via a blend-state model. International Journal of Pharmaceutics 561, pages 148-160.
Crossref
Crossref
Worth Longest & Dale Farkas. (2019) Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling. The AAPS Journal 21:2.
Crossref
Crossref
Sarah Zellnitz, Eva Roblegg, Joana Pinto & Eleonore Fröhlich. (2019) Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View. Current Drug Delivery 16:3, pages 180-194.
Crossref
Crossref
Dominique N. Price, Nitesh K. Kunda & Pavan Muttil. (2019) Challenges Associated with the Pulmonary Delivery of Therapeutic Dry Powders for Preclinical Testing. KONA Powder and Particle Journal 36:0, pages 129-144.
Crossref
Crossref
Gerald A. Hebbink & Bastiaan H.J. Dickhoff. 2019. Lactose. Lactose
175
229
.
Federico Lavorini, Francesca Buttini & Omar S. Usmani. 2019. Concepts and Principles of Pharmacology. Concepts and Principles of Pharmacology
143
159
.
Erin M. Wilson, J. Christopher Luft & Joseph M. DeSimone. (2018) Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery. Pharmaceutical Research 35:10.
Crossref
Crossref
Martyn F. Biddiscombe & Omar S. Usmani. (2018) Is there room for further innovation in inhaled therapy for airways disease?. Breathe 14:3, pages 216-224.
Crossref
Crossref
Ashlee D. Brunaugh & Hugh D.C. Smyth. (2018) Formulation techniques for high dose dry powders. International Journal of Pharmaceutics 547:1-2, pages 489-498.
Crossref
Crossref
Julia Paik, Lesley J. Scott & Roy A. Pleasants. (2018) Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma. Clinical Drug Investigation 38:5, pages 463-473.
Crossref
Crossref
Jonas Rudén, Göran Frenning, Tobias Bramer, Kyrre Thalberg & Göran Alderborn. (2018) Relationships between surface coverage ratio and powder mechanics of binary adhesive mixtures for dry powder inhalers. International Journal of Pharmaceutics 541:1-2, pages 143-156.
Crossref
Crossref
Francesca Buttini, Stavroula Rozou, Alessandra Rossi, Varvara Zoumpliou & Dimitrios M. Rekkas. (2018) The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers. European Journal of Pharmaceutical Sciences 113, pages 64-76.
Crossref
Crossref
Tomasz R. Sosnowski. (2018) Powder Particles and Technologies for Medicine Delivery to the Respiratory System: Challenges and Opportunities. KONA Powder and Particle Journal 35:0, pages 122-138.
Crossref
Crossref
E. Faulhammer, S. Zellnitz, T. Wutscher, S. Stranzinger, A. Zimmer & A. Paudel. (2018) Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation. International Journal of Pharmaceutics 536:1, pages 326-335.
Crossref
Crossref
Anthony J. Hickey. 2018. Inhaled Pharmaceutical Product Development Perspectives. Inhaled Pharmaceutical Product Development Perspectives
1
14
.
Nivedita Shetty, Lingfei Zeng, Sharad Mangal, Haichen Nie, Matthew R. Rowles, Rui Guo, Youngwoo Han, Joon Hyeong Park & Qi Zhou. (2018) Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations. Pharmaceutical Research 35:1.
Crossref
Crossref
Shahid Sukhbir Kaur. (2017) Pulmonary drug delivery system: newer patents. Pharmaceutical Patent Analyst 6:5, pages 225-244.
Crossref
Crossref